ABIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ABIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ARCA biopharma's ROE % for the quarter that ended in Jun. 2024 was -31.65%. ARCA biopharma's PB Ratio for the quarter that ended in Jun. 2024 was 1.71. ARCA biopharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -18.51%.
The historical data trend for ARCA biopharma's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ARCA biopharma Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
ROE % Adjusted to Book Value | Get a 7-Day Free Trial |
![]() |
![]() |
-66.98 | -43.88 | -64.93 | -26.11 | -20.25 |
ARCA biopharma Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
ROE % Adjusted to Book Value | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-19.79 | -19.42 | -17.34 | -30.52 | -18.51 |
For the Biotechnology subindustry, ARCA biopharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, ARCA biopharma's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where ARCA biopharma's ROE % Adjusted to Book Value falls into.
ARCA biopharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as
ARCA biopharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of ARCA biopharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
James P Flynn | director | 41 HARRIS CT, DANVILLE CA 94526 |
Funicular Funds, Lp | 10 percent owner, other: See Footnote 1 | 2261 MARKET STREET, #4307, SAN FRANCISCO CA 94114 |
Funicular Fund, Lp | other: See Footnote 1 | 2261 MARKET STREET, #4307, SAN FRANCISCO CA 94114 |
Jacob Ma-weaver | other: See Remarks | 2261 MARKET STREET, #4307, SAN FRANCISCO CA 94114 |
Christopher David Ozeroff | officer: S.V.P., General Counsel | 8001 ARISTA PLACE, SUITE 200, BROOMFIELD CO 80021 |
Robert E Conway | director | C/O ARCA BIOPHARMA, INC, 8001 ARISTA PLACE, STE 430, BROOMFIELD CO 80021 |
C. Jeffrey Dekker | officer: Chief Financial Officer | 10170 CHURCH RANCH WAY, WESTMINSTER CO 80021 |
Thomas A Keuer | officer: Chief Operating Officer | C/O ARCA BIOPHARMA, INC., 10170 CHURCH RANCH WAY, STE 100, WESTMINSTER CO 80021 |
Brian L. Selby | officer: VP, Finance | 11080 CIRCLEPOINT ROAD, SUITE 140, WESTMINSTER CO 80020 |
Venrock Healthcare Capital Partners Lp | 10 percent owner | 530 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10036 |
Scott D Sandell | 10 percent owner | |
David M Mott | 10 percent owner | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
Joshua Makower | 10 percent owner | 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043 |
Forest Baskett | 10 percent owner | |
Peter J Barris | 10 percent owner | 1119 ST PAUL STREET, BALTIMORE MD 21202 |
From GuruFocus
By sperokesalga sperokesalga • 02-24-2023
By GlobeNewswire • 07-21-2023
By PurpleRose PurpleRose • 07-11-2022
By Marketwired • 08-23-2024
By PRNewswire • 04-10-2024
By Value_Insider Value_Insider • 12-19-2022
By GuruFocus Research • 09-14-2024
By Marketwired • 08-29-2024
By PRNewswire • 05-23-2024
By PurpleRose PurpleRose • 07-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.